# Study to Determine the Performance of the Astron and Pulsar-18 Stents in Europe

Study · id `cardio:ct-nct01661231` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01661231](<https://clinicaltrials.gov/study/NCT01661231>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01661231

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 456 participants.

## Technical summary

Registry record NCT01661231. Allocation not applicable; no masking; primary purpose treatment. Start 2012-10 (registry gives no type); primary completion 2015-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 456 participants (planned count; ClinicalTrials.gov record NCT01661231, source copy `cardio:ctgov-nct01661231-2017-02-03`, retrieved 2026-10-31)
- Start date: 2012-10 (registry gives no type) (ClinicalTrials.gov record NCT01661231, source copy `cardio:ctgov-nct01661231-2017-02-03`, retrieved 2026-10-31)
- Primary completion: 2015-09 (actual) (ClinicalTrials.gov record NCT01661231, source copy `cardio:ctgov-nct01661231-2017-02-03`, retrieved 2026-10-31)
- Completion: 2018-10 (anticipated) (ClinicalTrials.gov record NCT01661231, source copy `cardio:ctgov-nct01661231-2017-02-03`, retrieved 2026-10-31)
- Countries: Austria; Belgium; Germany; Switzerland (ClinicalTrials.gov record NCT01661231, source copy `cardio:ctgov-nct01661231-2017-02-03`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01661231-2017-02-03`, retrieved 2026-10-31)

## The registry's words

- Brief title: Study to Determine the Performance of the Astron and Pulsar-18 Stents in Europe
- Acronym: BIOFLEX-I EU
- Condition: Peripheral Artery Disease
- Condition: Peripheral Vascular Disease
- Intervention (Device): Astron/Pulsar-18 stent
- Lead sponsor: Biotronik AG
- Lead sponsor class: INDUSTRY
- Collaborator: Biotronik, Inc.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Biotronik AG (`cardio:org-biotronik-ag`)
- Registry lists this organization as a collaborator: Biotronik, Inc. (`cardio:org-biotronik-inc`)

## Provenance

Content hash: f6119db20b69eee9295e33b465bdb5215d4aa0cbd686843ca01e4be2285e99c8
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
